BDSX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Biodesix Inc (BDSX).


$166.48M Market Cap.

As of 03/01/2024 5:00 PM ET (MRY) • Disclaimer

BDSX Market Cap. (MRY)


BDSX Shares Outstanding (MRY)


BDSX Assets (MRY)


Total Assets

$99.10M

Total Liabilities

$94.52M

Total Investments

$0

BDSX Income (MRY)


Revenue

$49.09M

Net Income

-$52.15M

Operating Expense

$77.42M

BDSX Cash Flow (MRY)


CF Operations

-$22.87M

CF Investing

-$23.06M

CF Financing

$29.13M

BDSX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

-

-

0%

-

BDSX Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$99,096,000 (6.66%)

$92,906,000 (22.09%)

$76,097,000 (-37.15%)

$121,070,000 (168.85%)

Assets Current

$39,683,000 (-25.60%)

$53,334,000 (22.29%)

$43,613,000 (-49.37%)

$86,140,000 (578.27%)

Assets Non-Current

$59,413,000 (50.14%)

$39,572,000 (21.82%)

$32,484,000 (-7.00%)

$34,930,000 (8.03%)

Goodwill & Intangible Assets

$22,942,000 (-7.60%)

$24,828,000 (-6.83%)

$26,648,000 (-5.81%)

$28,291,000 (-6.08%)

Shareholders Equity

$4,580,000 (-77.77%)

$20,606,000 (4.46%)

$19,727,000 (-52.08%)

$41,166,000 (118.28%)

Property Plant & Equipment Net

$29,612,000 (235.70%)

$8,821,000 (111.08%)

$4,179,000 (31.50%)

$3,178,000 (49.91%)

Cash & Equivalents

$26,284,000 (-39.00%)

$43,088,000 (31.72%)

$32,712,000 (-47.35%)

$62,126,000 (1075.29%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$324,000 (-66.32%)

$962,000 (-48.00%)

$1,850,000 (-47.62%)

$3,532,000 (175.29%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$7,679,000 (51.61%)

$5,065,000 (38.54%)

$3,656,000 (-76.11%)

$15,304,000 (189.19%)

Trade & Non-Trade Payables

$2,929,000 (73.83%)

$1,685,000 (1.38%)

$1,662,000 (-81.46%)

$8,964,000 (422.07%)

Accumulated Retained Earnings (Deficit)

-$419,566,000 (-14.19%)

-$367,420,000 (-21.67%)

-$301,973,000 (-16.68%)

-$258,814,000 (-13.78%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$60,691,000 (90.55%)

$31,850,000 (218.12%)

$10,012,000 (-63.94%)

$27,766,000 (-22.81%)

Debt Current

$303,000 (-80.97%)

$1,592,000 (8278.95%)

$19,000 (-99.84%)

$11,840,000 (-2.62%)

Debt Non-Current

$60,388,000 (99.58%)

$30,258,000 (202.79%)

$9,993,000 (-37.25%)

$15,926,000 (-33.12%)

Total Liabilities

$94,516,000 (30.73%)

$72,300,000 (28.26%)

$56,370,000 (-29.45%)

$79,904,000 (4.84%)

Liabilities Current

$33,416,000 (46.31%)

$22,839,000 (-21.14%)

$28,960,000 (-9.85%)

$32,125,000 (42.15%)

Liabilities Non-Current

$61,100,000 (23.53%)

$49,461,000 (80.45%)

$27,410,000 (-42.63%)

$47,779,000 (-10.88%)

BDSX Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$49,087,000 (28.46%)

$38,212,000 (-29.89%)

$54,506,000 (19.64%)

$45,557,000 (85.55%)

Cost of Revenue

$13,010,000 (-8.08%)

$14,154,000 (-53.62%)

$30,518,000 (38.73%)

$21,998,000 (262.17%)

Selling General & Administrative Expense

$67,387,000 (9.64%)

$61,462,000 (21.67%)

$50,517,000 (44.93%)

$34,857,000 (13.77%)

Research & Development Expense

$9,988,000 (-23.77%)

$13,102,000 (2.45%)

$12,789,000 (18.22%)

$10,818,000 (3.34%)

Operating Expenses

$77,419,000 (3.72%)

$74,645,000 (17.91%)

$63,306,000 (38.60%)

$45,675,000 (11.12%)

Interest Expense

$9,536,000 (18.14%)

$8,072,000 (79.06%)

$4,508,000 (-40.72%)

$7,604,000 (152.79%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$52,146,000 (20.32%)

-$65,447,000 (-51.64%)

-$43,159,000 (-37.67%)

-$31,350,000 (-2.03%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$52,146,000 (20.32%)

-$65,447,000 (-51.64%)

-$43,159,000 (-37.67%)

-$31,350,000 (-2.03%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$52,146,000 (20.32%)

-$65,447,000 (-51.64%)

-$43,159,000 (-37.67%)

-$31,350,000 (-2.03%)

Weighted Average Shares

$82,113,000 (95.03%)

$42,103,000 (53.86%)

$27,365,000 (465.63%)

$4,838,000 (1899.17%)

Weighted Average Shares Diluted

$82,113,000 (95.03%)

$42,103,000 (53.86%)

$27,365,000 (465.63%)

$4,838,000 (1899.17%)

Earning Before Interest & Taxes (EBIT)

-$42,610,000 (25.73%)

-$57,375,000 (-48.44%)

-$38,651,000 (-62.77%)

-$23,746,000 (14.33%)

Gross Profit

$36,077,000 (49.96%)

$24,058,000 (0.29%)

$23,988,000 (1.82%)

$23,559,000 (27.50%)

Operating Income

-$41,342,000 (18.28%)

-$50,587,000 (-28.66%)

-$39,318,000 (-77.78%)

-$22,116,000 (2.26%)

BDSX Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

-$23,062,000 (-552.57%)

-$3,534,000 (-38.75%)

-$2,547,000 (12.98%)

-$2,927,000 (-56.36%)

Net Cash Flow from Financing

$29,129,000 (-50.53%)

$58,882,000 (4565.77%)

$1,262,000 (-98.44%)

$81,131,000 (253.17%)

Net Cash Flow from Operations

-$22,870,000 (49.15%)

-$44,972,000 (-59.35%)

-$28,223,000 (-32.09%)

-$21,366,000 (1.66%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$16,803,000 (-261.94%)

$10,376,000 (135.16%)

-$29,508,000 (-151.92%)

$56,838,000 (9179.55%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

-$750,000 (-64.47%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$23,062,000 (-552.57%)

-$3,534,000 (-38.75%)

-$2,547,000 (-17.00%)

-$2,177,000 (-53.74%)

Issuance (Repayment) of Debt Securities

$9,118,000 (-28.62%)

$12,773,000 (182.33%)

-$15,514,000 (-196.72%)

$16,040,000 (22.97%)

Issuance (Purchase) of Equity Shares

$28,860,000 (-52.03%)

$60,162,000 (244.97%)

$17,440,000 (-76.22%)

$73,340,000 (155942.55%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$5,373,000 (-9.86%)

$5,961,000 (20.57%)

$4,944,000 (33.30%)

$3,709,000 (2081.76%)

Depreciation Amortization & Accretion

$5,507,000 (-5.77%)

$5,844,000 (83.89%)

$3,178,000 (9.47%)

$2,903,000 (3.94%)

BDSX Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

73.50% (16.67%)

63.00% (43.18%)

44.00% (-14.89%)

51.70% (-31.34%)

Profit Margin

-106.20% (38.00%)

-171.30% (-116.29%)

-79.20% (-15.12%)

-68.80% (45.00%)

EBITDA Margin

-75.60% (43.96%)

-134.90% (-107.22%)

-65.10% (-42.14%)

-45.80% (54.88%)

Return on Average Equity (ROAE)

-30185.80% (-3722.92%)

-789.60% (-348.13%)

-176.20% (-616.72%)

34.10% (135.17%)

Return on Average Assets (ROAA)

-60.60% (32.21%)

-89.40% (-98.67%)

-45.00% (-19.36%)

-37.70% (48.43%)

Return on Sales (ROS)

-86.80% (42.17%)

-150.10% (-111.71%)

-70.90% (-36.08%)

-52.10% (53.85%)

Return on Invested Capital (ROIC)

-71.00% (80.84%)

-370.50% (-137.50%)

-156.00% (-61.83%)

-96.40% (18.10%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-2.88 (-93.73%)

-1.48 (55.68%)

-3.35 (-7.62%)

-3.11

Price to Sales Ratio (P/S)

3.08 (21.47%)

2.53 (-4.59%)

2.66 (24.05%)

2.14

Price to Book Ratio (P/B)

36.35 (673.71%)

4.7 (-35.16%)

7.25 (-44.25%)

13

Debt to Equity Ratio (D/E)

20.64 (488.12%)

3.51 (22.78%)

2.86 (47.24%)

1.94 (672.57%)

Earnings Per Share (EPS)

-0.64 (58.71%)

-1.55 (1.90%)

-1.58 (75.62%)

-6.48 (94.90%)

Sales Per Share (SPS)

0.6 (-34.14%)

0.91 (-54.42%)

1.99 (-78.84%)

9.42 (-90.72%)

Free Cash Flow Per Share (FCFPS)

-0.56 (51.48%)

-1.15 (-2.49%)

-1.12 (76.90%)

-4.87 (94.91%)

Book Value Per Share (BVPS)

0.06 (-88.55%)

0.49 (-32.18%)

0.72 (-91.53%)

8.51 (100.91%)

Tangible Assets Book Value Per Share (TABVPS)

0.93 (-42.67%)

1.62 (-10.51%)

1.81 (-90.58%)

19.18 (-68.87%)

Enterprise Value Over EBIT (EV/EBIT)

-5 (-150.00%)

-2 (33.33%)

-3 (88.00%)

-25

Enterprise Value Over EBITDA (EV/EBITDA)

-5.32 (-160.78%)

-2.04 (42.11%)

-3.52 (87.40%)

-27.96

Asset Turnover

0.57 (9.20%)

0.52 (-8.26%)

0.57 (3.64%)

0.55 (-5.99%)

Current Ratio

1.19 (-49.12%)

2.33 (55.05%)

1.51 (-43.83%)

2.68 (377.05%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$45,932,000 (5.31%)

-$48,506,000 (-57.64%)

-$30,770,000 (-30.70%)

-$23,543,000 (-1.73%)

Enterprise Value (EV)

$197,384,383 (87.73%)

$105,145,082 (-15.90%)

$125,020,847 (-78.55%)

$582,861,951

Earnings Before Tax (EBT)

-$52,146,000 (20.32%)

-$65,447,000 (-51.64%)

-$43,159,000 (-37.67%)

-$31,350,000 (-2.03%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$37,103,000 (28.00%)

-$51,531,000 (-45.27%)

-$35,473,000 (-70.19%)

-$20,843,000 (16.38%)

Invested Capital

$77,145,000 (126.89%)

$34,001,000 (1637.81%)

-$2,211,000 (-108.41%)

$26,294,000 (14.35%)

Working Capital

$6,267,000 (-79.45%)

$30,495,000 (108.11%)

$14,653,000 (-72.87%)

$54,015,000 (645.61%)

Tangible Asset Value

$76,154,000 (11.86%)

$68,078,000 (37.67%)

$49,449,000 (-46.70%)

$92,779,000 (522.26%)

Market Capitalization

$166,476,383 (71.95%)

$96,815,082 (-32.27%)

$142,938,847 (-73.29%)

$535,072,951

Average Equity

$172,750 (-97.92%)

$8,288,750 (-66.16%)

$24,491,250 (126.62%)

-$91,986,500 (56.52%)

Average Assets

$86,074,500 (17.51%)

$73,246,000 (-23.58%)

$95,846,000 (15.41%)

$83,051,500 (97.53%)

Invested Capital Average

$60,034,250 (287.71%)

$15,484,500 (-37.49%)

$24,771,750 (0.52%)

$24,644,500 (4.62%)

Shares

90,476,295 (114.94%)

42,093,514 (55.78%)

27,020,576 (1.81%)

26,541,317 (0.46%)